BridgeBio Pharma, Inc. (BBIO)

68.14 -2.58 (-3.65%) USD  |  NASDAQ  |  Feb 20, 16:00
68.23 +0.09 (+0.13%) After-Hours: 05:43
More

BridgeBio Pharma Long Term Deferred Tax Liabilities (Quarterly)

Long Term Deferred Tax Liabilities (Quarterly) Chart

View Long Term Deferred Tax Liabilities (Quarterly) for BBIO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Liabilities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Liabilities (Quarterly) Benchmarks

View Long Term Deferred Tax Liabilities (Quarterly) Benchmarks
Start Trial
Insmed, Inc. --
Mirum Pharmaceuticals, Inc. --
Cogent Biosciences, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. --